CovClear™ enables businesses and communities to leverage low cost, high volume rapid testing to isolate positive cases.
The CovClear Rapid Antigen test is a immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasal swab specimen.
Key benefits
Simple to use – shallow nose swab only
Rapid results
Highly sensitive and specific
Safety advantage – biosafe sealed vial protecting collector against live virus
No reader required – reduced cost
No cassette needed – reduced material wastage
Researched, developed & manufactured in the USA